Practicalities of a reduced volume formulation of a C1-INH concentrate for the treatment of hereditary angioedema: real-life experience

Practicalities of a reduced volume formulation of a C1-INH concentrate for the treatment of hereditary angioedema: real-life experience

Abstract Background Hereditary angioedema (HAE) due to C1 esterase inhibitor (C1-INH) deficiency is characterized by recurrent swelling attacks that can be life-threatening if left untreated. Prompt treatment is vital during acute attacks; plasma-derived C1-INH (Berinert®) is one treatment currently...

Full description

Bibliographic Details
Main Author: John Dempster
Format: Article
Language:English
Published: BMC 2018-10-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Hereditary angioedema
HAE
C1 inhibitor
C1-INH
Reduced volume
Quality of Life
Online Access:http://link.springer.com/article/10.1186/s13223-018-0267-4

Internet

http://link.springer.com/article/10.1186/s13223-018-0267-4

Similar Items